You are viewing the site in preview mode

Skip to main content

Table 2 ORS and zinc treatment coverage by subgroup

From: Private health care market shaping and changes in inequities in childhood diarrhoea treatment coverage: evidence from the analysis of baseline and endline surveys of an ORS and zinc scale-up program in Nigeria

  Received ORS Received Zinc
  Baseline n = 1349%, 95 confidence interval Endline n = 2023%, 95 confidence interval Endline - Baseline Difference 95% confidence interval, P-value* Baseline n = 1333%, 95 confidence interval Endline n = 2000%, 95 confidence interval Endline - Baseline Difference 95% confidence interval, P-value*
Residence of households
 Urban 44 (36–51) 50 (49–54) 6 (− 3.2–15), 0.210 6 (3–9) 29 (25–33) 23 (18–28), <  0.001
 Rural 39 (35–42) 57 (53–60) 18 (13–23), <  0.001 5 (4–7) 38 (35–41) 33 (29–36), <  0.001
Wealth quintiles
 Poorest 28 (22–35) 50 (44–56) 21 (12–31), <  0.001 3 (1–5) 35 (30–40) 33 (27–38), <  0.001
 Second 37 (28–46) 51 (46–57) 15 (4–25), 0.006 3 (1–6) 31 (25–36) 27 (21–33), <  0.001
 Middle 43 (34–52) 47 (41–53) 4 (−7–15), 0.462 4 (1–6) 25 (20–29) 21 (16–26), <  0.001
 Fourth 47 (37–56) 54 (47–60) 7 (−5–18), 0.242 7 (3–10) 33 (29–38) 27 (21–32,), <  0.001
 Richest 50 (52–58) 67 (61–73) 17 (7.3–27), 0.001 10 (5–15) 40 (40–52) 36 (28–44), <  0.001
  1. *P-values were generated using Wald’s chi-squared tests
\